Analysis of hepatitis C virus (HCV) RNA load in platelets of HCV-monoinfected patients receiving antiviral therapy

Journal Title: Annals of Hepatology - Year 2013, Vol 12, Issue 3

Abstract

[b]Introduction[/b]. Detection of hepatitis C virus (HCV) has been reported in extrahepatic sites such as peripheral blood mononuclear cells and platelets. Quantitation of HCV-RNA in platelets from patients under antiviral therapy has not been reported. [b]Material and methods[/b]. HCV-RNA levels in paired serum and platelet samples of 17 chronically HCV-infected patients were determined at baseline, week 12, end-of-treatment, and 24 weeks after completion of treatment with pegylated interferon plus ribavirin. Quantitation of HCVRNA load was performed using COBAS® TaqMan® HCV Test v 2.0 (lower limit of detection, 25 IU/mL). The cohort predominantly consisted of female (59%) with a mean age of 50.7 ± 10.0 years. [b]Results[/b]. Measurements of HCV-RNA in relation to different timepoints of therapy revealed baseline viral load was most frequently detected in higher levels in serum than in platelets (5.6 x 104 IU/mL vs. 379.0 IU/mL; p = 0.0002), a trend also demonstrated in most samples throughout the study. HCV-RNA was also found at low levels (< 25.0-314.0 UI/mL) persistently in platelets of three patients who have lost detectable HCV-RNA in serum during antiviral therapy, resulting in virological relapse. [b]Conclusion[/b]. HCV-RNA levels are most frequently detected in higher levels in serum than in platelets, independent of timepoint of antiviral therapy. Further studies with an increase in size of the samples are needed to better evaluate whether or not patients who presented HCV-RNA at low levels in platelets after having lost detectable HCV-RNA in serum during antiviral therapy are at increased risk of relapse of HCV infection during follow-up evaluation.

Authors and Affiliations

Márcia do Espírito-Santo, Carlos Brandão-Mello, Vanessa Marques, Elisabeth Lampe, Adilson De Almeida

Keywords

Related Articles

The effect of celecoxib on the development of diethylnitrosamine-induced liver tumors in rats

[b]Background/aims[/b]. Hepatocellular carcinoma is one of the most commonly diagnosed malignant tumors in the world, and it typically has a poor prognosis. Extensive studies have examined the effects of non-steroidalant...

Association of amino acid imbalance with the severity of liver fibrosis and esophageal varices

[b]Background[/b]. The relationships between the metabolic parameters and the endoscopic findings of esophageal varices have been poorly investigated. We investigated the association of the branched-chain amino acids tot...

The epidemiologic burden of hepatitis C virus infection in Latin America

Chronic infection with hepatitis C virus (HCV) is a major and growing public health concern worldwide, including in Latin America. With more efficacious therapies becoming available, decision-makers will require accurat...

Usefulness of acoustic radiation force impulse and fibrotest in liver fibrosis assessment after liver transplant

Background and rationale. Acoustic radiation force impulse (ARFI) is a non-invasive tool used in the evaluation of liver fibrosisin HCV positive immune-competent patients. This study aimed to assess the accuracy of ARFI...

Deep sequencing analysis of microRNA expression in porcine serum-induced hepatic fibrosis rats

Aim. Recent studies have suggested miRNA dysregulation in liver tissue mediates the pathogenesis of various liver diseases especially liver fibrosis, but the microRNA changes during PS-induced hepatic fibrosis are still...

Download PDF file
  • EP ID EP78276
  • DOI -
  • Views 127
  • Downloads 0

How To Cite

Márcia do Espírito-Santo, Carlos Brandão-Mello, Vanessa Marques, Elisabeth Lampe, Adilson De Almeida (2013). Analysis of hepatitis C virus (HCV) RNA load in platelets of HCV-monoinfected patients receiving antiviral therapy. Annals of Hepatology, 12(3), 373-379. https://europub.co.uk./articles/-A-78276